INTRODUCTION
Shedding of microparticles (MP) is a vital phenomenon frequently observed during cell activation and apoptosis (Freyssinet, 2003) . These vesicles can be released by virtually all cell types but endothelial, blood, smooth muscle and cancer cells are the most studied cell types concerning the capacity to produce MP (Martinez et al., 2005) . Although MP were long considered as cellular debris with no biological significance, recent studies have demonstrated a potential role of these structures as mediators of cellular interactions (Martinez et al., 2005; Millimaggi et al., 2007) . MP can thus transfer bioactive molecules from one cell to another and serve as subcellular vectors to propagate signals. They have been shown to have significant roles in vascular dysfunction (Martinez et al., 2005) (Agouni et al., 2008) , in inflammation (Distler et al., 2006) or during abnormal fibrosis (Jiang et al., 2009 ). Furthermore, their increased concentration in blood of patients under pathological states such as immune disorders (Distler et al., 2006) or vascular diseases (Boulanger et al., 2006) , strengthens the notion that MP may play a role in numerous diseases. On the other hand, even if MP are present in blood of healthy individuals, few studies have shown a role of MP during normal physiological mechanisms (Freyssinet, 2003) .
Wound healing is a complex biological process where numerous cell types play a role. The interactions between each cell populations are crucial to correctly regulate each phase of the healing process (Moulin, 1995) . Whereas inflammatory cells have the major role during the inflammation phase, endothelial cells, epithelial cells and myofibroblasts are the main actors of the granulation tissue phase. Myofibroblasts are cells that mainly differentiate from fibroblasts to contract wound edges and secrete new matrix (Gabbiani, 2003; Moulin et al., 1999) . Matrix reconstruction, angiogenesis and reepithelialization are three mechanisms that need well organized interactions between different cell populations to correctly take place. It is accepted that communication between all these cells occurs via cytokines and growth factors secretion into the extracellular environment. However, the exact means of secretion is unclear. Numerous factors can be directly secreted into the extracellular fluid but it has also been demonstrated that membrane vesicles can represent a mechanism for regulating interactions between cells (Taraboletti et al., 2002; Taverna et al., 2003) . Furthermore, even though the production of MP -4-by endothelial cells has been documented (Taraboletti et al., 2002) , the production of MP by myofibroblast and fibroblast is still unknown.
In this study, we have shown that myofibroblasts isolated from skin granulation tissue produced a high quantity of MP in the presence of serum or plasma. In contrast, fibroblasts or myofibroblasts isolated from hypertrophic scars did not. The production of MP depended on the addition of a >30kDa-protein present in the body fluids, and was not found to be related to the induction of apoptosis in the cells. The MP produced by myofibroblasts contained VEGF and FGF2 and modulate cell growth. We thus postulate that MP production by myofibroblasts could modulate (myo)fibroblast growth and angiogenesis during the process of normal healing.
MATERIALS AND METHODS

Cell culture
The human skin primary cells used in these experiments were dermal fibroblasts (Fb), normal wound (WMyo) and hypertrophic scar myofibroblasts (HMyo). WMyo from normal human granulation tissue were obtained, as previously described (Germain et al., 1994) , from implants inserted subcutaneously into the arms of 20 to 40 year-old volunteers. HMyo were isolated from tissue obtained after corrective surgeries in clinically clear-cut cases of human hypertrophic scarring. Fb were isolated from human skin biopsies obtained during the myofibroblast implant surgeries (Rompré et al., 1990) . Microvascular endothelial cells (EC) were isolated from the dermis as described in Rochon et al (Rochon et al., 2001) . After isolation, cells were analyzed to evaluate their purity and phenotype using immunohistochemistry techniques.
The numbers indicated after each population refer to the numbers that were assigned to the individuals from which the cells were isolated.
Fb and HMyo were cultured in the Dulbecco-Vogt modification of Eagle's medium (DMEM; Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco BRL), 100U/ml penicillin, and 25µg/ml gentamicin (Sigma. St. Louis, MO, USA). WMyo were cultured under similar conditions but required addition of 20% FBS for better growth. EC were cultured in EGM-2MV (Lonza:Clonetics, San Diego, CA, USA) on gelatin-coated flask. These -5-cells were grown at 37 o C in a humidified incubator with 8% CO 2 . Preconfluent cell cultures between passages 3 and 6 were used in this study. All specimens were obtained after the informed consent of donors according to the principles expressed in the Declaration of Helsinki.
For all experiments, the results were confirmed for at least three separate cell populations.
Human serum and plasma preparation
Pools of human serum and plasma were obtained from 15 healthy donors according to the principles expressed in the Declaration of Helsinki. Two tubes (7 ml each) (one heparinized and one not) of blood were taken from each volunteer. After centrifugation, supernatants were pooled, aliquoted and frozen at -80 o C. Fetal bovine serum (FBS) (Hyclone, Logan, UT, USA) was also tested. 
Cell treatment and MP detection
Biochemical analysis of the serum
Serum was subjected to one of the following treatments before being tested on cells as described above. Heat treatment:10 ml DMEM containing 10% serum (or control DMEM without serum)
was heated in a water bath at 86 0 C for 40 minutes and then quickly cooled down in ice. Trypsin:
2 mg of trypsin (Intergen, Toronto, ON, Canada) was added to 2 ml of serum to produce a final concentration of 1 mg/ml. The media were incubated at 37 0 C for 60 minutes with the proteolysis terminated with 2 mg soybean trypsin inhibitor (Sigma). Control was similarly obtained except that trypsin was added at the same time as the soybean inhibitor. Molecular sieve: 10ml DMEM containing 10% serum or plasma was centrifuged in a Vivaspin 15R (5 000, 10 000 or 30 000 MWCO) (VWR, Mississauga, ON, Canada) at 4 o C. When each solution was concentrated 10 times, each filtrate was separately stored and resulting filtered solution was further diluted with 10 ml of DMEM without serum or plasma, and centrifuged to concentrate another 10 times.
DMEM was added to the remaining solution to obtain a 10 ml final volume.
Determination of cell apoptosis
Cell apoptosis was evaluated using AnnexinV/PI binding (R&D, Minneapolis, MN, USA) and TUNEL assay (R&D) as described in . Caspase-3 activity measurement was performed using the Apo Alert Caspase 3 assay kit (Clontech, Palo Alto, CA, USA). Fas antibody (Upstate, NY, USA) treatment (50ng/ml in presence of 5µg/ml cycloheximide (Sigma)) was used as a positive control.
Characterization of MP phenotype
The presence of α2-integrin protein on membrane of cells and MP was analyzed using flow cytometry on freshly trypsinized cells or MP isolated from the same cells using α2-integrin antibodies directly coupled with FITC as described in (Moulin et al., 2001) . Annexin V binding was used to numerate phosphatidylserin-expressing MP as described in .
VEGF and FGF2 were quantified using ELISA according to the manufacturer protocols (Peprotech, New Jersey, USA).
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Cell growth stimulation using MP
The day before treatment, cells were plated at a density 15 000 (Wmyo or Fb) or 25 000 (EC) cells/well in 12-well plates (BD Biosciences, Mississauga, ON, Canada). After 24 hours, 3 wells were trypsinized to evaluate the exact number of cells in each well and other wells containing cells were then treated with MP isolated from Wmyo culture (5 and 10 µg protein/ml) in basal medium containing 0.5% FBS for 6 days before being trypsinized and counted using a Coulter® counter. Controls were performed using 100 pg/ml FGF2 (Wmyo or Fb) or EBM2 with 5% FBS (EC). Results were expressed in percentage of the cell number obtained after 24 hours of seeding.
Statistical analysis
Statistical differences were computed by analysis of variance followed by the unpaired Student's t-test or non-parametric SNK test (Scherrer, 1984) . The results were considered significant when the p value was less than 0.05. All data presented are the means (errors bars: ±Standard-Deviation). The action of serum was found to be concentration-dependant ( Figure 2A ) and independent of the origin of fluids (human or bovine) ( Figure 2B ). Human plasma induced similar results (data not shown).
RESULTS
To
Characterization of molecules affecting MP production
To characterize the biochemical nature of mediator(s) present(s) in serum or plasma responsible for the increased production of MP observed in Wmyo, several analysis were performed.
Treatment of serum with heat or trypsin impeded the serum-induced increase of MP production by Wmyo ( Figure 3A) . Indeed, the production of MP was not increased when heat-treated or trypsin-treated serums were used in contrast to the use of untreated serum. Furthermore, sieving of the molecules present in the serum, using a low-binding filter that allows extracting molecules with a molecular mass smaller than 10 kDa, did not affect the increased production of MP detected after serum treatment. Similarly, Wmyo cultured in the presence of serum sieved through a filter to eliminate molecules with a molecular weight smaller than 30 kDa was found to produce similar amount of MP when compared to non-sieved serum ( Figure 3B ). Results were similar if human or bovine sera were used (data not shown).
The action of several known proteins was also investigated on the various cell populations tested in this study. These molecules were chosen because of their quantitative importance in serum (albumin, immunoglobulin) (Anderson and Anderson, 2002) , of their role in wound healing process (PDGF, TGFß) (Moulin, 1995) (Rizzo et al., 1999) ; FGF2: 1.54±1.98 pg/ml (Larsson et al., 2002) .
None of the five proteins tested were found to modulate the number of MP detected after treating Wmyo (data not shown).
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Apoptosis
As apoptosis is the most known mechanism at the origin of MP production, the apoptotic rate of WMyo after FBS treatment was investigated. The use of three different methods to detect apoptosis demonstrated that culture of WMyo in the presence of FBS was not found to significantly induce apoptosis in comparison to the culture in the absence of FBS (Figure 4 ). In contrast, Fas antibody treatment induced a high apoptotic level in these same Wmyo cells.
Characterization of MP produced by Wmyo
Since MP are vesicles derived from the plasma membrane of the original cells (Freyssinet, 2003) , we validated this finding by evaluating the presence of a plasma membrane antigen: α2-integrin on the surface of the MP produced by the WMyo cells tested. As shown in Figure 5A , the presence of α2-integrin antigens was detected in plasma membranes of Wmyo and in the MP produced by these cells.
Another phenomenon of the MP is that their formation is also associated with the loss of plasma membrane asymmetry (Zwaal and Schroit, 1997) . We have analyzed this parameter using annexin V binding of the outer leaflet phosphatidylserin and found that almost all of MP produced can bind annexin V ( Figure 5B ). The presence of these two parameters confirms that particles produced by WMyo were indeed MP as described in the literature.
VEGF and FGF2 presence in MP has been assayed since these two molecules are potent cytokines involved in cell interactions during wound healing. MP from WMyo contained VEGF (0.66±0.10 pg/µg protein (N=3 cell populations)) and FGF2 (15.51±2.52 pg/µg protein (N=3 cell populations)), whereas these two growth factors were undetectable in non-conditioned medium ( Figure 5C ).
Effect of MP on cell growth
To demonstrate the potential role of MP during wound healing, Wmyo, Fb and EC were treated for 6 days with two MP concentrations isolated from Wmyo. Figure 6 shows that MP significantly increased the number of cells of the three population types when 5 and 10 µg/ml of -10-total MP proteins were used suggesting that MP can influence cell number during wound healing.
Stimulation with the higher dose of MP induced a similar growth than when 100pg/ml FGF2 (Fb and Wmyo) or EBM2 with 5%FBS (EC) were used. Cells stimulated with non-conditioned medium preparation didn't stimulate any cell growth. In the past, this communication was thought to be exclusively due to direct secretion of factors into extracellular space. Since the discovery that MP are not only the dusts of death cells but also mediators between cells, numerous authors have hypothesized a role of MP during wound healing. To this end, angiogenesis has been demonstrated to be modulated by MP produced by platelets or EC themselves (Taraboletti et al., 2002) . In the present study, we have demonstrated that Wmyo, but not Hmyo or Fb, can also produce MP which stimulate in vitro EC growth, and thus potently in vivo angiogenesis. The MP produced by Wmyo also stimulated Wmyo and Fb cell growth, enhancing the number of matrix-producing mesenchymal cells at the wound site.
DISCUSSION
Presence of VEGF and FGF2 into MP are consistent with the documented presence of these two factors during healing (Shukla et al., 1998) . VEGF is a strong angiogenic factor which is involved in EC growth as well as in capillary formation (Hughes, 2008) , whereas FGF2
stimulates the growth of Fb and EC (Gospodarowicz, 1991) . Furthermore, the presence of FGF2 in MP has already been described as a mode for the cells to secrete this growth factor which has no conventional secretory signal sequence (Taverna et al., 2003) . Production of MP by Wmyo can thus be described as a general means by which Wmyo can interact with granulation tissue cells.
Circulating MP and their role during cardiovascular or immunological diseases have been extensively evaluated (Distler et al., 2006) (Boulanger et al., 2006) tissues are considered to be in a more stable state than wounds. The cells continue to produce matrix but generate little angiogenesis (Niessen et al., 1999) . To our knowledge, this is one of the first studies demonstrating the role of MP production by local cells during a normal (i.e. non pathological) physiological phenomenon.
In culturing nucleated cells, levels of MP released into the supernatant have been correlated with the degree of apoptosis (Freyssinet, 2003) . Apoptosis is therefore believed to constitute the main mechanism at the origin of the MP production. We have however demonstrated that the MP production by Wmyo is not linked to apoptotic induction of these cells as also demonstrated by few other groups using smooth muscle cells or EC (Jimenez et al., 2003; Llorente-Cortes et al., 2004; Taraboletti et al., 2002) . In these studies, the MP production is triggered by FGF2, TNF or lipoproteins. We have found that serum or plasma can also stimulate MP production. In vivo, the cell environment is made of matrix and fluids containing secretions produced by adjacent cells or carried from the blood. Plasma is the body fluid at the origin of the extracellular fluid, while serum is only present in the tissues when a wound appears. Both of these body fluids are constituted of a large number of substances with very different concentrations: from 35-50 mg/ml for serum albumin to 0-5 pg/ml for interleukin-6 (Anderson and Anderson, 2002) . Addition of serum in culture medium inhibits apoptosis and stimulates growth of fibroblasts (Chen et al., 2003) . However, serum can also induce the production of MP by Wmyo, as our study demonstrates. To characterize the biochemical nature of mediator(s) present(s) in serum or plasma and capable of increasing MP production by Wmyo, we have performed several analysis and shown that the observed effect of these body fluids on the MP production was at least linked to thermally sensitive protein(s) with a molecular mass greater than 30 000D. This effect was not -12-due to TGFß, PDGF, FGF2, albumin or immunoglobulins as these molecules were not found to have any effect on this response.
This study shows differences in MP production between myofibroblasts and fibroblasts in response to normal body fluids. During normal wound healing, differentiation of fibroblasts to normal myofibroblasts induces a stronger cell sensitivity to one or more body fluid proteins.
Production of MP in response to these signals could transfer bioactive molecules such as growth factors from myofibroblasts to other cells present into the wound, and serve as subcellular vectors to propagate signals and to participate to the orchestrated mechanisms of the healing process. -17- Analysis of a non-conditioned medium preparation indicated that no VEGF or FGF2 was present in the control (*: p<0.05 vs. control). 
